 Bank of New York Mellon Corp boosted its position in Aclaris Therapeutics Inc NASDAQ:ACRS by 76.9 during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 219,779 shares of the biotechnology companys stock after buying an additional 95,527 shares during the quarter. Bank of New ... 